Use of 3,4-diphenyl chromans for the manufacture of a...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/40 (2006.01) A61K 31/35 (2006.01) A61K 31/4025 (2006.01)

Patent

CA 2241559

The present invention provides novel uses of compounds of formula (I) wherein R1, R4 and R5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, C1- 6-alkyl, C1-6-alkoxy or (tertiary amino)(C1-6-alkoxy); and R2 and R3 are individually hydrogen or C1-6-alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma.

Cette invention se rapporte à de nouvelles utilisations de composés représentés par la formule générale (I), où R?1¿, R?4¿ et R?5¿ représentent séparément hydrogène, hydroxy, halogène, trifluorométhyle, C¿1-6?-alkyle, C¿1-6?-alcoxy ou (C¿1-6?-alcoxy)(amino tertiaire); et R?2¿ et R?3¿ représentent séparément hydrogène ou C¿1-6?-alkyle; ou d'un sel pharmaceutiquement acceptable de ces composés, en association avec un excipient pharmaceutiquement acceptable, dans la fabrication d'une composition pharmaceutique servant au traitement ou à la prophylaxie du cancer de la prostate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of 3,4-diphenyl chromans for the manufacture of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 3,4-diphenyl chromans for the manufacture of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3,4-diphenyl chromans for the manufacture of a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1658838

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.